Evidence map›Paper›PMID 39808620›Full record

ArticlePloS one2025

A novel combinatorial approach integrating experimental and computational analysis of antioxidant activity: Evaluating catechin and L-ascorbic acid in serum.

Ayeshum Rasool, Chinanu Chidi, Sophie Rigaut, Symone Carty, Chirine Soubra-Ghaoui, Richa Chandra

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ayeshum RasoolChemistry and Biochemistry, University of St. Thomas, Houston, TX, United States of America.
Chinanu ChidiChemistry and Biochemistry, University of St. Thomas, Houston, TX, United States of America.
Sophie RigautChemistry and Biochemistry, University of St. Thomas, Houston, TX, United States of America.
Symone CartyChemistry and Biochemistry, University of St. Thomas, Houston, TX, United States of America.ORCID 0009-0000-3063-9241
Chirine Soubra-GhaouiChemistry and Biochemistry, University of St. Thomas, Houston, TX, United States of America.
Richa ChandraChemistry and Biochemistry, University of St. Thomas, Houston, TX, United States of America.ORCID 0000-0002-7754-5901

Funding

US Department of Education STEM Grant AWARD NUMBER P031C160188
6 · The paper itself

Abstract

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality globally, with oxidative stress playing a pivotal role in its progression. Free radicals produced via oxidative stress contribute to lipid peroxidation, leading to subsequent inflammatory responses, which then result in atherosclerosis. Antioxidants inhibit these harmful effects through their reducing ability, thereby preventing oxidative damage. In this study, we introduce computational models simulating hydrophilic and hydrophobic serum environments. We optimized the Ferric Reducing Ability of Plasma (FRAP) assay at a microscale level to evaluate the antioxidant activity of L-ascorbic acid (vitamin C) and catechin, a phytochemical found in green tea, in normal and hypertriglyceridemic serum. Hypertriglyceridemic serum, characterized by increased hydrophobic lipid content, provides a model to examine the impact of serum triglycerides on antioxidant activity. Additionally, we employed computational models using the Gaussian software to simulate the hydrogen atom transfer (HAT) mechanism, calculating free energy changes and bond dissociation energy (BDE) to assess the antioxidant potency of the studied compounds in both hydrophilic and hydrophobic environments. The computational results align with the experimental finding offering a unique combinatorial approach to assess antioxidant activity in both normal and hypertriglyceridemic serum, with potential implications for clinical interventions.

Indexed as

AntioxidantsAscorbic AcidCatechinComputer SimulationHumansHydrophobic and Hydrophilic InteractionsHypertriglyceridemiaTriglyceridesAntioxidantsAscorbic AcidCatechinTriglycerides

Identifiers

PMID39808620
PMCPMC11731726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.